To homepage

Best Online Consultation with Oncologist Doctors Abroad

Content meets the Bookimed Editorial Policy and is medically reviewed by

Mustafa Serkan Alemdar

  • 4.4 Good • 8 reviews
  • 20 years of experience
  • Turkey, Antalya, Medical Park Antalya Hospital Complex
  • Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

    • Treats a wide range of cancers including breast, lung, and prostate.
    • Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
    • Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
    • Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.
  • Read more
Package price from
$1,100
Info

Auala Hubert

  • 4.2 Good • 13 reviews
  • 36 years of experience
  • accreditation:
  • Israel, Jerusalem, Hadassah Medical Center
  • Dr. Auala Hubert heads the Gastrointestinal Cancer Center at Hadassah Medical Center. He provides online consultation with oncologist services for digestive system tumors.

    • Dual-qualified as a medical oncologist and a radiotherapist
    • Specializes in esophagus, stomach, pancreas, and colon cancers
    • Expert in HIPEC – delivering heated chemotherapy directly into the abdomen
    • Certified by the American USMLE for high medical standards
    • Member of the Israel Society of Clinical Oncology
  • Read more
Package price from
$2,190
Info

Ali Ihsan Anadolulu

  • 17 years of experience
  • Turkey, Istanbul, Central Hospital
  • Dr. Ali Ihsan Anadolulu leads internal medicine at Central Hospital. He provides online consultations for patients seeking expert guidance on complex digestive and oncologic issues.

    • Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical schools
    • Specializes in gastroenterology and internal medicine to address systemic health concerns
    • Performs advanced endoscopic procedures for precise diagnostic evaluations
    • Authored numerous scientific publications and textbooks to educate other physicians
    • Focuses on pediatric gastrointestinal surgery and minimally invasive techniques
  • Read more
Package price from
$5,000
Info

Irfan Cicin

  • 5 Excellent • 1 review
  • 29 years of experience
  • Turkey, Istanbul, İstinye University Liv Hospital Topkapı
  • Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

    • Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
    • Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
    • Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
    • Works at a 300-bed university hospital with 33 medical departments.
  • Read more
Doctor's visit
Price on request
Info

Muhammed Mustafa Atci

  • 5 Excellent • 1 review
  • 15 years of experience
  • Turkey, Istanbul, İstinye University Liv Hospital Topkapı
  • Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

    • Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
    • Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
    • Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
    • Treats complex oncological cases at the university-affiliated İstinye University clinic.
  • Read more
Doctor's visit
Price on request
Info

Havva Asuman Yavuz

  • 4.4 Good • 8 reviews
  • 28 years of experience
  • Turkey, Antalya, Medical Park Antalya Hospital Complex
  • Dr. Havva Asuman Yavuz is a nephrologist at Medical Park Antalya Hospital Complex. She completed a fellowship in critical care nephrology and transplantation at San Bortolo Hospital in Italy. Dr. Yavuz specializes in organ transplantation and complex kidney care. She works at the largest private hospital in the Mediterranean region.

    • Member of the International Society of Nephrology and the European Society of Nephrology.
    • Performs robotic nephrectomy using the Da Vinci surgical system.
    • Treats chronic kidney disease, performing dialysis and kidney biopsies.
    • Holds an Associate Professorship from Hacettepe University Faculty of Medicine.
  • Read more
Package price from
$1,100
Info

Seyda Gunduz

  • 4.2 Good • 19 reviews
  • 16 years of experience
  • Turkey, Istanbul, Istinye University Liv Hospital Bahcesehir
Package price from
$1,000
Info

Enriqueta Felip

  • 4.4 Good • 6 reviews
  • 39 years of experience
  • accreditations:
  • Spain, Barcelona, Hospital Quiron Barcelona
  • Prof. Enriqueta Felip is the President of the Oncology Commission at Vall d’Hebron University Hospital. She provides online consultations for patients with lung cancer and thoracic malignancies.

    • Received the first ESMO Women for Oncology Award for her professional leadership
    • Professor of Medicine at the Universitat de Vic training future oncologists
    • Leads clinical trials investigating new therapies and pharmacogenomic methods for personalized care
    • Board member of the International Association for the Study of Lung Cancer (IASLC)
    • Vice-President of the Spanish Society of Medical Oncology (SEOM) until recently
  • Read more
Package price from
$30,000
Info

Nir Kleinmann

  • 5 Excellent • 2 reviews
  • 25 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

    • Completed urological fellowships at Thomas Jefferson University and McMaster University.
    • Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
    • Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
    • Fellow of the American Endourology Society with over 60 scientific publications.
  • Read more
Package price from
$950
Info

Raanan Berger

  • 5 Excellent • 2 reviews
  • 27 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

    • Heads the clinical research unit focusing on molecular oncology.
    • Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
    • Member of the American Society of Clinical Oncology (ASCO).
    • Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.
  • Read more
Package price from
$950
Info

Jair Bar

  • 5 Excellent • 2 reviews
  • 35 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

    • Chair of the Israel Lung Cancer Group.
    • Board-certified in both Medical Oncology and Radiotherapy Oncology.
    • Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
    • Uses molecular and genetic profiling to create precise cancer treatment plans.
  • Read more
Package price from
$950
Info

Beni Boursi

  • 5 Excellent • 2 reviews
  • 21 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Prof. Beni Boursi is a leading specialist at Sheba Medical Center. He provides expert second opinions during an online consultation with an oncologist.

    • Trained in gastrointestinal oncology at the University of Pennsylvania
    • Completed elective medical oncology training at MD Anderson Cancer Center
    • Founded the ECOG-ACRIN Microbiome Working Group to study cancer treatment response
    • Developed predictive models for early diagnosis of colorectal and pancreatic cancers
    • Published research in top-tier scientific journals including Science
  • Read more
Package price from
$950
Info

Avichai Shimoni

  • 5 Excellent • 2 reviews
  • 31 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

    • Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
    • Authored over 250 scientific papers on cellular therapies and transplantation.
    • Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
    • Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.
  • Read more
Package price from
$950
Info

Abraham Avigdor

  • 5 Excellent • 2 reviews
  • 35 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

    • Authored over 130 scientific publications on hemato-oncology and cellular therapy.
    • Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
    • Leads allogeneic and autologous bone marrow transplantation programs.
    • Served as the Chairman of the Israeli Lymphoma Study Group.
  • Read more
Package price from
$950
Info

Hila Magen

  • 5 Excellent • 2 reviews
  • 35 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

    • Authored over 100 scientific publications and landmark myeloma studies.
    • Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
    • Performs CAR-T cell therapy and bone marrow transplantations.
    • Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.
  • Read more
Package price from
$950
Info

Iris Kventsel

  • 5 Excellent • 2 reviews
  • 36 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

    • Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
    • Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
    • Published in major journals on stem cell biology and surgical oncology (HIPEC).
    • Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.
  • Read more
Package price from
$950
Info

Eytan Aharon Ben-ami

  • 5 Excellent • 2 reviews
  • 20 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

    • Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
    • Authored over 40 scientific publications on molecular mechanisms and early detection.
    • Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
    • Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.
  • Read more
Package price from
$950
Info

Yaacov Lawrence

  • 5 Excellent • 2 reviews
  • 31 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

    • Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
    • Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
    • Authored over 280 scientific publications on personalized radiation protocols.
    • Completed radiation oncology fellowship training at Thomas Jefferson University.
  • Read more
Package price from
$950
Info

Zhang Jinshan

  • 41 years of experience
  • 50000+ treatments performed
  • China, Chengdu, Uni-asia Cancer hospital
  • Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

    1980–1985: Completed doctoral studies at Nagasaki University, Japan

    1968–present: Department of Radiology, Chinese PLA General Hospital

    1988: Third Prize of the Military Science and Technology Progress Award

    1989–present: Member of Radiological Society of North America(RSNA)

    1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

    1991: Second Prize of the Military Science and Technology Progress Award

    1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

    1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

    1993: Granted the Lifetime Special Government Allowance of the State Council

    1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

    1994: Third Prize of the Military Science and Technology Progress Award

    1997: Second Prize of the Military Science and Technology Progress Award

    1997–2009: Standing Member of Chinese Society of Radiology

    1999: Third Prize of the Military Science and Technology Progress Award

    1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

    2002: Second Prize of the Military Science and Technology Progress Award

    2005: Third Prize of the Military Science and Technology Progress Award

    Member of Radiological Society of North America(RSNA)

    Standing Member of Chinese Society of Radiology

    Group Leader of the Group of Intervention of Chinese Journal of Radiology

    Deputy Director Member of Chinese Society of Interventional Oncology

    Director Member of Beijing Medical Association Society of Interventional Radiology

    Deputy Chief Editor of Chinese Journal of Medical Image Technology

    Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

    Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

    Awarded the Special Government Allowance of the State Council

    Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

    Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

    Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

    In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

    zhang-jin-shan

    Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

    zhang-jin-shan

    In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

    zhang-jin-shan

    Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

    zhang-jin-shan

    From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

    Professor Zhang Jinshan’s Academic Achievements

    Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

    Selected Publications by Professor Zhang Jinshan

    1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993,27(6):361-365.

    Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

    2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996,30(8):521-524.

    Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

    3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998,14(3):189-191.

    Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

    4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000,34(5):335-337.

    Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

    5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002,36(7):612-614.

    Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

    6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004,20(9):1395-1397.

    Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

    7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006,40(8):876-878.

    Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

    8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008,28(10):856-858.

    Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

    Professor Zhang Jinshan co-authored monographs

    1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

    2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

    3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

    Professor Zhang Jinshan’s Research project

    1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

    2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

    3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

    4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

  • Read more
Package price from
$2,500
Info

Francesc Bosch

  • 4.4 Good • 6 reviews
  • 126 years of experience
  • Spain, Barcelona, Hospital Quiron Barcelona
  • Dr. Francesc Bosch leads the experimental hematology laboratory at Vall d’Hebron Hospital. He offers online consultation with oncologist for chronic lymphocytic leukemia and lymphomas.

    • Directs over 80 clinical trials testing new blood cancer drugs
    • President of the Spanish Group for Chronic Lymphocytic Leukemia study
    • Published over 100 articles in journals like Nature Medicine
    • Specializes in molecular technologies to analyze hematological diseases
    • Completed a post-doctoral fellowship at Columbia University in New York
  • Read more
Package price from
$30,000
Info